Grey Wolf Animal Health Corp.

Consumer Cyclical CA WOLF

1.73CAD
0.12(7.45%)

Last update at 2026-06-03T20:00:00Z

Day Range

1.651.73

LowHigh

52 Week Range

0.901.55

LowHigh

Fundamentals

Previous Close 1.61
Market Cap50.60M
Volume219800
P/E Ratio29.60
Dividend Yield-%
EBITDA5.57M
Revenue TTM33.47M
Revenue Per Share TTM0.99
Gross Profit TTM 17.76M
Diluted EPS TTM0.05

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Income before tax	2.38M	1.39M	1.10M	1.75M	-1.89112M
Minority interest	-	-	-	-	-
Net income	1.66M	0.70M	0.61M	2.54M	-0.96894M
Selling general administrative	12.94M	10.64M	10.06M	10.62M	6.01M
Selling and marketing expenses	-	-	-	-	-
Gross profit	19.06M	13.76M	12.83M	11.56M	7.15M
Reconciled depreciation	2.70M	1.53M	1.45M	1.56M	1.12M
Ebit	-	-	-	-	0.13M
Ebitda	-	-	-	-	-
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	4.06M	1.91M	1.55M	-0.35595M	0.07M
Other operating expenses	-	-	-	-	-
Interest expense	1.77M	0.66M	0.60M	6.68M	1.66M
Tax provision	0.72M	0.69M	0.49M	-0.79678M	-0.92219M
Interest income	0.11M	0.20M	0.15M	-	-
Net interest income	-1.66219M	-0.46101M	-0.45030M	-6.68215M	-1.65510M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-0.92219M
Total revenue	35.76M	26.83M	25.41M	22.64M	13.10M
Total operating expenses	31.71M	24.92M	23.86M	22.99M	13.03M
Cost of revenue	16.70M	13.07M	12.58M	11.07M	5.95M
Total other income expense net	-0.01738M	-0.05242M	-0.00617M	8.78M	-0.30643M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	1.66M	0.70M	0.61M	2.54M	-0.96894M
Net income applicable to common shares	-	-	-	-	-0.96894M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total assets	64.53M	65.60M	41.41M	39.31M	36.23M
Intangible assets	16.66M	18.34M	9.52M	10.50M	11.58M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	-
Total liab	33.96M	36.77M	16.32M	15.06M	32.16M
Total stockholder equity	30.56M	28.83M	25.09M	24.25M	4.08M
Deferred long term liab	-	-	-	-	-
Other current liab	-	-	-	-	4.06M
Common stock	-	-	-	-	9.69M
Capital stock	31.53M	31.53M	28.58M	28.58M	9.69M
Retained earnings	-6.32390M	-7.98064M	-8.68531M	-9.29489M	-11.83809M
Other liab	-	-	-	-	1.83M
Good will	24.20M	24.20M	13.89M	13.89M	13.89M
Other assets	-	-	-	-	-
Cash	7.67M	6.41M	7.78M	6.86M	4.35M
Cash and equivalents	-	-	-	-	-
Total current liabilities	6.21M	6.17M	5.42M	4.99M	19.51M
Current deferred revenue	-	-	-	-	-
Net debt	17.39M	20.46M	1.40M	3.25M	18.77M
Short term debt	-	-	-	-	-
Short long term debt	2.17M	2.07M	1.06M	1.06M	13.10M
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	-	5.33M
Property plant equipment	-	-	-	-	2.29M
Total current assets	16.07M	14.51M	14.36M	12.89M	8.47M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	-	-21.39634M
Short term investments	-	-	-	-	-
Net receivables	2.25M	2.21M	1.69M	1.95M	1.12M
Long term debt	22.88M	24.80M	8.12M	9.05M	10.03M
Inventory	5.56M	5.48M	4.63M	3.76M	2.87M
Accounts payable	3.68M	3.99M	4.12M	3.69M	2.22M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	48.46M	51.09M	27.06M	26.42M	27.76M
Capital lease obligations	0.42M	0.73M	0.74M	0.92M	0.92M
Long term debt total	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Investments	-	-20.46912M	-0.28444M	4.36M	-23.23761M
Change to liabilities	-	-	-	-	0.79M
Total cashflows from investing activities	-	-	-	-	-23.23761M
Net borrowings	-2.05811M	17.37M	-1.22382M	-	22.29M
Total cash from financing activities	-2.05811M	17.35M	-1.22382M	-1.13810M	23.32M
Change to operating activities	-	-	-	-	-0.06698M
Net income	1.66M	0.70M	0.61M	2.54M	-0.96894M
Change in cash	1.25M	-1.37403M	0.93M	2.51M	2.22M
Begin period cash flow	6.41M	7.78M	6.86M	4.35M	2.13M
End period cash flow	7.67M	6.41M	7.78M	6.86M	4.35M
Total cash from operating activities	3.83M	1.75M	2.43M	-0.71028M	2.14M
Issuance of capital stock	-	-	-	0.00000M	2.48M
Depreciation	2.70M	1.53M	1.45M	1.56M	1.12M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-0.08304M	-0.39092M	-0.86280M	-0.89566M	-0.21170M
Change to account receivables	-	-	-	-	0.55M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	-	-	-1.45492M
Change to netincome	-	-	-	-	0.80M
Capital expenditures	0.52M	0.53M	0.28M	0.05M	0.01M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	-0.89942M	-0.93558M	-0.13880M	-0.60772M	1.06M
Stock based compensation	0.08M	0.09M	0.23M	0.21M	0.18M
Other non cash items	0.09M	0.24M	0.13M	5.52M	1.48M
Free cash flow	3.31M	1.21M	2.15M	-0.76404M	2.12M

Peer Comparison

Sector: Consumer Cyclical Industry: Personal Services

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
WOLF Grey Wolf Animal Health Corp.	0.12 7.45%	1.73	29.60	-	1.51	1.66	1.91	9.98
MNLX MiniLuxe Holding Corp	- -%	0.33	-	-	2.12	5.79	1.81	-2.754
RMB Rumbu Holdings Ltd.	0.05 8.62%	0.63	-	-	1.33	17.12	2.34	27.66
WPR White Pine Resources Inc.	- -%	0.05	-	-	0.48	0.73	0.50	1.41

Reports Covered

View All

Profile

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, cohesive bandages, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves. It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products. The company is headquartered in Toronto, Canada.

Grey Wolf Animal Health Corp.

Bay Adelaide ? West Tower, Toronto, ON, Canada, M5H 2R2

https://greywolfah.com

Key Executives

Name	Title	Year Born
Ms. Angela Cechetto	Chief Exec. Officer	NA
Dr. Ian Sandler	Founder, Director & CVMO	NA
Mr. Kevin S. Palmer C.A., CPA, M.B.A.	Chief Financial Officer	NA
Mr. Brandon Mair-Wren	VP of Operations	NA
Mr. Murray Roach	C.C.O.	NA
Ms. Angela Cechetto	CEO & Secretary	NA
Dr. Ian Sandler	Founder, Chief Veterinary Medical Officer & Director	NA
Mr. Brandon Mair-Wren	Vice President of Operations	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.